Connors Investor Services Inc. lifted its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 31.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 113,567 shares of the financial services provider’s stock after acquiring an additional 27,042 shares during the quarter. Connors Investor Services Inc. owned approximately 0.27% of Trupanion worth $3,339,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also made changes to their positions in the business. Sivia Capital Partners LLC purchased a new position in Trupanion during the fourth quarter valued at $31,398,000. 8 Knots Management LLC purchased a new position in shares of Trupanion in the 4th quarter worth about $21,165,000. Wellington Management Group LLP boosted its stake in Trupanion by 34.6% in the 4th quarter. Wellington Management Group LLP now owns 2,453,685 shares of the financial services provider’s stock worth $74,862,000 after purchasing an additional 630,155 shares in the last quarter. Renaissance Technologies LLC bought a new position in Trupanion in the 2nd quarter worth about $4,739,000. Finally, Hosking Partners LLP purchased a new stake in Trupanion during the 2nd quarter valued at about $3,523,000.
Insider Activity
In other news, CFO Fawwad Qureshi sold 640 shares of Trupanion stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $43.12, for a total value of $27,596.80. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Trupanion news, CEO Margaret Tooth sold 7,500 shares of the firm’s stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the transaction, the chief executive officer now owns 99,984 shares of the company’s stock, valued at $4,647,256.32. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CFO Fawwad Qureshi sold 640 shares of the firm’s stock in a transaction on Friday, August 16th. The stock was sold at an average price of $43.12, for a total value of $27,596.80. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 8,764 shares of company stock valued at $405,238. 5.50% of the stock is currently owned by company insiders.
Trupanion Stock Down 1.1 %
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its earnings results on Thursday, August 8th. The financial services provider reported ($0.14) EPS for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.04. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The firm had revenue of $314.80 million during the quarter, compared to analysts’ expectations of $309.33 million. During the same quarter in the previous year, the business earned ($0.33) EPS. The company’s quarterly revenue was up 16.3% on a year-over-year basis. As a group, equities analysts expect that Trupanion, Inc. will post -0.37 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
TRUP has been the subject of several recent analyst reports. Piper Sandler lifted their target price on shares of Trupanion from $30.00 to $38.00 and gave the stock a “neutral” rating in a report on Friday, August 9th. Evercore ISI upgraded Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Northland Securities upped their target price on shares of Trupanion from $30.00 to $35.00 and gave the company a “market perform” rating in a report on Friday, August 9th. Stifel Nicolaus reiterated a “hold” rating and set a $30.00 target price (up from $22.00) on shares of Trupanion in a research report on Friday, August 9th. Finally, William Blair assumed coverage on shares of Trupanion in a report on Friday, July 19th. They issued an “outperform” rating for the company. Four analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Trupanion currently has a consensus rating of “Moderate Buy” and an average target price of $36.17.
Read Our Latest Stock Analysis on TRUP
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Recommended Stories
- Five stocks we like better than Trupanion
- Golden Cross Stocks: Pattern, Examples and Charts
- Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
- What is Short Interest? How to Use It
- Silver’s Breakout: 3 Momentum Stocks You Can’t Miss
- Buy P&G Now, Before It Sets A New All-Time High
- Top 3 Dividend Stocks to Beat Market Volatility and Boost Returns
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.